Diatranz denies trans-Tasman plans
17 July, 2002 by Tanya HollisA New Zealand company working on a pig-derived cure for type 1 diabetes has denied reports of a planned move to Australia.
Red tape hampering Sirtex at home
17 July, 2002 by Pete YoungThe US is embracing Sirtex Medical's novel anti-cancer technology more quickly than Australia where government evaluation of the technology appears to have stalled.
Circadian appoints all-rounder to board
16 July, 2002 by Tanya HollisAustralian biomedical research developer Circadian Technologies has appointed an accountant with a diverse business background to its board.
BresaGen revamps board ahead of strategy refocus
16 July, 2002 by Tanya HollisA board reshuffle aimed at sharpening the focus of Adelaide biotherapy company BresaGen is underway. The company has announced the resignations of three board members and the appointment of an existing director to the chairman's position.
New Zealand feature: NZ lures high-flying Scot to head biotech
12 July, 2002 by Iain ScottSimilarities between New Zealand and Scotland are plentiful - the agrarian industries, the scenery, the weather. But one of the less heralded similarities is the two places' biotechnology industries - or at least, it was, before Scotland's received a major boost about four years ago.
New Zealand feature: solid biotech is lacking investors
12 July, 2002 by Tanya HollisIn terms of industry size, New Zealand and Australia have a similar number of biotech companies operating on their respective shores.
Victoria to host synchrotron conference in 2005
09 July, 2002 by Tanya HollisVictoria has beaten a host of other nations to win the right to stage an international synchrotron conference in 2005.
$2m government grant for Melbourne Institute
09 July, 2002 by Tanya HollisMelbourne's St Vincent's Institute of Medical Research has attracted a $2 million Victorian government grant to boost its research facilities.
Monash launches first stage of science precinct construction
04 July, 2002 by Melissa TrudingerMonash University has officially launched the first stage of construction for its on-campus Science, Technology, Research and Innovation Precinct (STRIP), even though the first building is already well on its way up.
New Gradipore CEO makes his mark with restructure
04 July, 2002 by Iain ScottThe new US-based CEO of bioseparations specialist Gradipore has wasted no time in making his mark on the company, announcing changes to its management structure during a visit to Australia.
Autogen stocks soar as Gutnick sells out
03 July, 2002 by Tanya HollisMining magnate Joseph Gutnick has relinquished his stake in Autogen in a move that allows the gene discovery company a more complete biotech focus.
Rathjen nets top job at Adelaide science faculty
02 July, 2002 by Melissa TrudingerLeading stem cell scientist Prof Peter Rathjen has been appointed executive dean of the new Faculty of Sciences at the University of Adelaide.
Iatia's technology wins R&D 100 Award
02 July, 2002 by Tanya HollisMelbourne vision sciences company Iatia has taken out the top award for optical imaging technology in a prestigious international competition.
McComas steps down from EpiTan board
02 July, 2002 by Tanya HollisInvestment banker Malcolm McComas has resigned from the board of Melbourne tanning drug company EpiTan after almost three years.
Victorian TAFE to offer biotech degrees
01 July, 2002 by Tanya HollisBiotechnology will be among a raft of specialised degrees on offer at Victorian TAFE institutes.
